NKGEN Biotech
Pre-clinicalNKGen Biotech is leveraging the power of a patient's immune system through the development of unique natural killer (NK) cell therapies.
Founded
2017
Focus
BiologicsCell & Gene Therapy
About
NKGen Biotech is leveraging the power of a patient's immune system through the development of unique natural killer (NK) cell therapies.
Funding History
2Total raised: $75M
Series B$50MUndisclosedNov 15, 2022
Series A$25MUndisclosedAug 15, 2020
Company Info
TypePrivate
Founded2017
LocationSanta Ana, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile